Dow Down 0.17% Nasdaq Down 0.28%

Northwest Biotherapeutics, Inc. (NWBO)

-NasdaqCM
5.03 Down 0.18(3.45%) 4:00PM EDT
Prev Close:5.21
Open:5.22
Bid:4.92 x 200
Ask:5.02 x 1000
1y Target Est:5.00
Beta:2.85
Next Earnings Date:N/A
Day's Range:5.00 - 5.22
52wk Range:3.10 - 10.64
Volume:462,162
Avg Vol (3m):499,620
Market Cap:299.31M
P/E (ttm):N/A
EPS (ttm):-2.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NWBO

Comparison

Symbol% ChgMkt Cap
NWBODown 3.45%299.31M
AGENDown 0.64%194.93M
DNDNDown 5.26%223.82M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):775.04
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Northwest Biotherapeutics, Inc., a development stage biotechnology company, discovers and develops immunotherapy products to treat cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback